Compare Edwards Lifesciences Corporation Common Stock (EW) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs CarMax, Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while CarMax, Inc trades at $54 (market cap $7.64B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 6.4× CarMax, Inc's market cap, and CarMax, Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | KMX | |
|---|---|---|
Market Cap | $48.56B | $7.64B |
Volume | 6,520,488 | 3,610,116 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $64.22 |
52-Week Low | $72.65 | $30.88 |
Enterprise Value | $45.01B | $25.34B |
Typical Hold Time | — | 49 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CarMax (KMX) trades at $53.28, down 3.64% amid a bearish technical signal, though recent Q2 2027 earnings beat estimates with EPS of $1.16 versus $0.732 expected. The company reported 19.5% revenue growth to $7.9 billion, driven by strong unit sales and cost control. Analyst consensus is mixed with 29.73% buy ratings and a $58.89 price target, while technical indicators show support at $52-$53 and resistance at $54.
The outlook is cautiously optimistic as CarMax's turnaround strategy shows early traction, but high debt levels and thin net margins near 1% pose risks. Near-term catalysts include the November strategic update, though macroeconomic pressures on consumer spending could challenge sustained growth. The stock offers value with a P/S of 0.28, but investors should monitor execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
